Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLysitsas, D. N.en
dc.contributor.authorKatsouras, C. S.en
dc.contributor.authorPapakostas, J. C.en
dc.contributor.authorToumpoulis, I. K.en
dc.contributor.authorAngelidis, C.en
dc.contributor.authorBozidis, P.en
dc.contributor.authorThomas, C. G.en
dc.contributor.authorSeferiadis, K.en
dc.contributor.authorPsychoyios, N.en
dc.contributor.authorFrillingos, S.en
dc.contributor.authorPavlidis, N.en
dc.contributor.authorMarinos, E.en
dc.contributor.authorKhaldi, L.en
dc.contributor.authorSideris, D. A.en
dc.contributor.authorMichalis, L. K.en
dc.rightsDefault Licence-
dc.subjectAnalysis of Varianceen
dc.subjectBalloon Dilation/instrumentationen
dc.subject*Blood Vessel Prosthesis Implantationen
dc.subjectBlotting, Westernen
dc.subjectCoated Materials, Biocompatibleen
dc.subjectGraft Occlusion, Vascular/*prevention & controlen
dc.subjectIliac Artery/*surgeryen
dc.subjectMicroscopy, Electron, Scanningen
dc.subjectMicroscopy, Fluorescenceen
dc.subjectModels, Animalen
dc.subjectProsthesis Designen
dc.subjectRandom Allocationen
dc.subjectStainless Steelen
dc.subjectTunica Intima/*drug effects/pathologyen
dc.titleAntirestenotic effects of a novel polymer-coated d-24851 eluting stent. Experimental data in a rabbit iliac artery modelen
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.abstractExperimental and clinical data suggest that stents eluting antiproliferative agents can be used for the prevention of in-stent restenosis. Here we investigate in vitro the antiproliferative and apoptotic effect of D-24851 and evaluate the safety and efficacy of D-24851-eluting polymer-coated stents in a rabbit restenosis model (n = 53). Uncoated stents (n = 6), poly (DL: -lactide-co-glycolide) (PLGA)-coated stents (n = 7), and PLGA-coated stents loaded with 0.08 +/- 0.0025 microM (31 +/- 1 mug; low dose; n = 7), 0.55 +/- 0.02 microM (216 +/- 8 mug; high dose; n = 6), and 4.55 +/- 0.1 microM (1774 +/- 39 mug; extreme dose; n = 5) of D-24851 were randomly implanted in New Zealand rabbit right iliac arteries and the animals were sacrificed after 28 days for histomorphometric analysis. For the assessment of endothelial regrowth in 90 days, 12 rabbits were subjected to PLGA-coated (n = 3), low-dose (n = 3), high-dose (n = 3), and extreme-dose (n = 3) stent implantation. In vitro studies revealed that D-24851 exerts its growth inhibitory effects via inhibition of proliferation and induction of apoptosis without increasing the expression of heat shock protein-70, a cytoprotective and antiapoptotic protein. Treatment with low-dose D-24851 stents was associated with a significant reduction in neointimal area and percentage stenosis only compared with bare metal stents (38% [P = 0.029] and 35% [P = 0.003] reduction, respectively). Suboptimal healing, however, was observed in all groups of D-24851-loaded stents in 90 days in comparison with PLGA-coated stents. We conclude that low-dose D-24851-eluting polymer-coated stents significantly inhibit neointimal hyperplasia at 28 days through inhibition of proliferation and enhancement of apoptosis. In view of the suboptimal re-endothelialization, longer-term studies are needed in order to establish whether the inhibition of intimal growth is maintained.en
heal.journalNameCardiovasc Intervent Radiolen
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
File Description SizeFormat 
Lysitsas-2007-Antirestenotic effec.pdf394.3 kBAdobe PDFView/Open    Request a copy

This item is licensed under a Creative Commons License Creative Commons